newsfilter
← Latest News
PR Newswire·

CTI BioPharma to Participate in Two Upcoming Investor Conferences in April 2023

SEATTLE, Wash., April 12, 2023 /PRNewswire/ -- CTI BioPharma Corp. (NASDAQ:CTIC), a commercial biopharmaceutical company focused on the development and commercialization of novel targeted therapies for blood-related